Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Tillner J, Posch MG, Wagner F, Teichert L, Hijazi Y, Einig C, et al
A high protein diet is associated with improved glycemic control following exercise among adolescents with type 1 diabetes
10.3389/fnins.2022.970925 Front
Here's what you should know going in: Commonly reported effects include nausea, vomiting, diarrhea, and constipation, particularly during initial dose escalation Warnings and precautions in the prescribing information for applicable semaglutide and tirzepatide products cover pancreatitis, gallbladder disease, and kidney injury associated with volume depletion If you're on insulin or sulfonylureas, discuss hypoglycemia risk with your prescriber - GLP-1 medications can affect blood sugar control when combined with those drugs These medications slow gastric emptying, which can affect how orally taken medications are absorbed - worth flagging if you take other oral drugs regularly Certain FDA-approved semaglutide and tirzepatide products carry a boxed warning concerning thyroid C-cell tumors observed in rodents
